Question: is palbociclib available on the nhs?
Answer: The National Institute for Health and Care Excellence (NICE) has today announced that major new breast cancer drugs palbociclib (Ibrance, Pfizer) and ribociclib (Kisqali, Novartis) are to be made routinely available to NHS patients in England, in new draft guidance following their technology appraisals.